Stocktwits Inc

According to Bloomberg, a monthly prescription of Zepbound via Hims' platform would cost $1,899 — $800 more than Lilly's list price for the drug.

Shares are up a whopping 2,230% from the company's initial public offering (IPO) price of $10.

Ives said the uncertainty around tariffs could create caution about broader spending and greenlighting artificial intelligence (AI) projects across all industries.

Earlier, analysts at RBC Capital noted that while Enphase has a strong opportunity to return to growth eventually, in the near term, the company continues to cede market share amid softening demand.

Red Cat recorded a net loss of $0.57 per share on $4.9 million in revenue for the final eight months of 2024, with 2025 revenue guidance of $80 million to $120 million.

Subscription revenue jumped 16% YoY to $125 million, exceeding the guidance of $122.5 million to $124.5 million.

IBKR announced a 44% year-over-year jump in its daily average revenue trades to 3.471 million. Client accounts rose 32% YoY to 3.62 million during the month.

Duke Energy stated that Sideris will focus on guiding the company’s future by overseeing its $83 billion five-year capital plan and driving critical infrastructure investments to support economic growth and meet customer energy demands.

According to Bloomberg, Commerce Secretary Howard Lutnick has indicated he may withhold Chips Act grants as he presses semiconductor companies to expand their U.S. manufacturing investments.

The reverse split will reduce the number of shares of common stock issued and outstanding from approximately 54.5 million to approximately 2.8 million.